Skip to main content

Table 2 ECMO blood flow and microcirculatory parameters of 28-day survivors and nonsurvivors at T1, T2, T3, T4, and T5

From: Investigation of microcirculation in patients with venoarterial extracorporeal membrane oxygenation life support

Parameters

28-day survivors

28-day nonsurvivors

p

T1 (within 12 h after ECMO placement)

(n = 24)

(n = 24)

 

 ECMO blood flow (L/min)

2.3 (0.8)

2.5 (0.6)

0.191

 TSVD (mm/mm2)

22.5 (2.7)

22.0 (3.5)

0.576

 HI

0.30 (0.1–0.44)

0.38 (0.09–0.71)

0.909

T2 (24 h after ECMO placement)

(n = 22)

(n = 21)

 

 ECMO blood flow (L/min)

2.2 (0.4)

2.5 (0.5)

0.022

 TSVD (mm/mm2)

22.8 (3.6)

22.8 (3.4)

0.994

 HI

0.21 (0–0.41)

0.24 (0.18–0.57)

0.269

T3 (48 h after ECMO placement)

(n = 19)

(n = 15)

 

 ECMO blood flow (L/min)

2.1 (0.4)

2.5 (0.9)

0.176

 TSVD (mm/mm2)

21.7 (4.4)

22.7 (3.4)

0.442

 HI

0.2 (0.07–0.3)

0.33 (0.14–0.44)

0.040

T4 (72 h after ECMO placement)

(n = 17)

(n = 11)

 

 ECMO blood flow (L/min)

2.2 (0.4)

2.8 (1.2)

0.097

 TSVD (mm/mm2)

23.8 (3.4)

21.8 (4.5)

0.177

 HI

0.14 (0.05–0.25)

0.18 (0.05–0.32)

0.353

T5 (96 h after ECMO placement)

(n = 17)

(n = 9)

 

 ECMO blood flow (L/min)

2.1 (0.6)

3.0 (1.4)

0.089

 TSVD (mm/mm2)

23.3 (2.9)

21.3 (4.8)

0.183

 HI

0.31 (0.1–0.54)

0.18 (0–0.56)

0.458

  1. Data are presented as mean (SD) or median (interquartile range)
  2. ECMO extracorporeal membrane oxygenation life support system, HI heterogeneity index, TSVD total small vessel density